Medical News: AHA: Niacin Bests Ezetimibe as Add-On Therapy - in Meeting Coverage, AHA from MedPage Today
Links shared publicly online about this topic.
- 1,599total visits
Medical News: AHA: Niacin Bests Ezetimibe as Add-On Therapy - in Meeting Coverage, AHA from MedPage Today
ORLANDO -- In high-risk patients on long-term statin therapy, boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis than going for addition
View full resource at medpagetoday.com
Tags: Heart Disease, Circulatory Disorders, Atherosclerosis, Cholesterol, Cholesterol Medication, Vitamin, Zetia, Niaspan
Most Recently Shared on November 16, 2009 at 2:07 am By:
Niacin bests ezetimibe (Zetia) as add-on therapy - in meeting coverage from AHA. More: http://bit.ly/2SCcHe (via @medpagetoday)
Also Shared By:
Medical News: AHA: Niacin Bests Ezetimibe as Add-On Therapy - in Meeting Coverage, AHA from MedPage Today
medpagetoday.com — “ORLANDO -- In high-risk patients on long-term statin therapy, boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis than going for addition” View full resource at medpagetoday.com
Most Recently Shared on November 16, 2009 at 2:32 am By:
Evelyn Tribole Nutritionist, Dietitian, and Active Health Library
Niacin (a B-vitamin) bests cholesterol-lowering drug Zetia as Add-On Therapy. http://bit.ly/3owktn
Advertisement
MedPage Today
@medpagetoday
Niacin bests ezetimibe (Zetia) as add-on therapy - in meeting coverage from AHA. More: http://bit.ly/2SCcHe
1 year ago...